Inmune Bio, Inc. (INMB) stock
INMBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.96+0.01 (+1.44%)
Close on Nov 17, 2026Market cap $26.64MP/E –Yield –
Inmune Bio price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Inmune Bio's price to sales ratio was 468.9× on Oct 31, 2023, against 466.6× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Oct 31, 2023 | 468.9× | +210.3 |
| 2022 | Dec 30, 2022 | 258.6× | – |
See a number that looks wrong?